Schedule 13G ownership disclosure

ATHIRA PHARMA INC

Common Stock, $0.0001 Par Value · CUSIP: 04746L104

Event date: 2025-12-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ACORN BIOVENTURES, L.P.

    Shares: 210,730.00 · Class: 2.2%

  • ACORN CAPITAL ADVISORS GP, LLC

    Shares: 210,730.00 · Class: 2.2%

  • ACORN BIOVENTURES 2, L.P.

    Shares: 291,009.00 · Class: 3.0%

  • Acorn Capital Advisors GP 2, LLC

    Shares: 291,009.00 · Class: 3.0%

  • Anders Hove

    Shares: 501,739.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001636587-25-000065
Form type
SCHEDULE 13G
Filer
ACORN BIOVENTURES, L.P.
CIK
CIK 1766853
Filed
Dec 23, 2025
Reporting period
Dec 22, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub